Literature DB >> 22002512

Effect of phosphate-based glass fibre surface properties on thermally produced poly(lactic acid) matrix composites.

Maziar Shah Mohammadi1, Ifty Ahmed, Naser Muja, Christopher D Rudd, Martin N Bureau, Showan N Nazhat.   

Abstract

Incorporation of soluble bioactive glass fibres into biodegradable polymers is an interesting approach for bone repair and regeneration. However, the glass composition and its surface properties significantly affect the nature of the fibre-matrix interface and composite properties. Herein, the effect of Si and Fe on the surface properties of calcium containing phosphate based glasses (PGs) in the system (50P(2)O(5)-40CaO-(10-x)SiO(2)-xFe(2)O(3), where x = 0, 5 and 10 mol.%) were investigated. Contact angle measurements revealed a higher surface energy, and surface polarity as well as increased hydrophilicity for Si doped PG which may account for the presence of surface hydroxyl groups. Two PG formulations, 50P(2)O(5)-40CaO-10Fe(2)O(3) (Fe10) and 50P(2)O(5)-40CaO-5Fe(2)O(3)-5SiO(2) (Fe5Si5), were melt drawn into fibres and randomly incorporated into poly(lactic acid) (PLA) produced by melt processing. The ageing in deionised water (DW), mechanical property changes in phosphate buffered saline (PBS) and cytocompatibility properties of these composites were investigated. In contrast to Fe10 and as a consequence of the higher surface energy and polarity of Fe5Si5, its incorporation into PLA led to increased inorganic/organic interaction indicated by a reduction in the carbonyl group of the matrix. PLA chain scission was confirmed by a greater reduction in its molecular weight in PLA-Fe5Si5 composites. In DW, the dissolution rate of PLA-Fe5Si5 was significantly higher than that of PLA-Fe10. Dissolution of the glass fibres resulted in the formation of channels within the matrix. Initial flexural strength was significantly increased through PGF incorporation. After PBS ageing, the reduction in mechanical properties was greater for PLA-Fe5Si5 compared to PLA-Fe10. MC3T3-E1 preosteoblasts seeded onto PG discs, PLA and PLA-PGF composites were evaluated for up to 7 days indicating that the materials were generally cytocompatible. In addition, cell alignment along the PGF orientation was observed showing cell preference towards PGF.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22002512     DOI: 10.1007/s10856-011-4453-x

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  32 in total

1.  Microarchitectural and mechanical characterization of oriented porous polymer scaffolds.

Authors:  Angela S P Lin; Thomas H Barrows; Sarah H Cartmell; Robert E Guldberg
Journal:  Biomaterials       Date:  2003-02       Impact factor: 12.479

2.  Soluble phosphate glass fibres for repair of bone-ligament interface.

Authors:  M Bitar; J C Knowles; M P Lewis; V Salih
Journal:  J Mater Sci Mater Med       Date:  2005-12       Impact factor: 3.896

3.  Modulation of polycaprolactone composite properties through incorporation of mixed phosphate glass formulations.

Authors:  Maziar Shah Mohammadi; Ifty Ahmed; Benedetto Marelli; Christopher Rudd; Martin N Bureau; Showan N Nazhat
Journal:  Acta Biomater       Date:  2010-03-03       Impact factor: 8.947

4.  Preparation of poly(epsilon-caprolactone)/continuous bioglass fibre composite using monomer transfer moulding for bone implant.

Authors:  G Jiang; M E Evans; I A Jones; C D Rudd; C A Scotchford; G S Walker
Journal:  Biomaterials       Date:  2005-05       Impact factor: 12.479

5.  Mechanical properties of highly porous PDLLA/Bioglass composite foams as scaffolds for bone tissue engineering.

Authors:  J J Blaker; V Maquet; R Jérôme; A R Boccaccini; S N Nazhat
Journal:  Acta Biomater       Date:  2005-09-01       Impact factor: 8.947

6.  In vitro evaluation of poly(epsilon-caprolactone-co-DL-lactide)/ bioactive glass composites.

Authors:  Jaana Rich; Tiina Jaakkola; Teemu Tirri; Timo Närhi; Antti Yli-Urpo; Jukka Seppälä
Journal:  Biomaterials       Date:  2002-05       Impact factor: 12.479

7.  Effect of composition on the release kinetics of phosphate controlled release glasses in aqueous medium.

Authors:  Huasheng Gao; Tianen Tan; Dahui Wang
Journal:  J Control Release       Date:  2004-04-16       Impact factor: 9.776

8.  Effect of increasing titanium dioxide content on bulk and surface properties of phosphate-based glasses.

Authors:  Ensanya Ali Abou Neel; Wojciech Chrzanowski; Jonathan Campbell Knowles
Journal:  Acta Biomater       Date:  2007-12-07       Impact factor: 8.947

9.  In vitro bioactivity and gene expression by cells cultured on titanium dioxide doped phosphate-based glasses.

Authors:  Ensanya Ali Abou Neel; Toshihide Mizoguchi; Michio Ito; Malak Bitar; Vehid Salih; Jonathan Campbell Knowles
Journal:  Biomaterials       Date:  2007-03-18       Impact factor: 12.479

10.  Processing, characterisation and biocompatibility of iron-phosphate glass fibres for tissue engineering.

Authors:  I Ahmed; C A Collins; M P Lewis; I Olsen; J C Knowles
Journal:  Biomaterials       Date:  2004-07       Impact factor: 12.479

View more
  3 in total

1.  Development of Functional Composite Cu(II)-Polyoxometalate/PLA with Antimicrobial Properties.

Authors:  Ella Duvanova; Illia Krasnou; Andres Krumme; Valdek Mikli; Serhii Radio; Georgiy M Rozantsev; Yevgen Karpichev
Journal:  Molecules       Date:  2022-04-13       Impact factor: 4.927

2.  Development of Natural-Based Bone Cement for a Controlled Doxorubicin-Drug Release.

Authors:  Rebecca Marie Dewhurst; Annachiara Scalzone; Joseph Buckley; Clara Mattu; Kenneth S Rankin; Piergiorgio Gentile; Ana Marina Ferreira
Journal:  Front Bioeng Biotechnol       Date:  2020-07-09

3.  Poly(d,l-Lactic acid) Composite Foams Containing Phosphate Glass Particles Produced via Solid-State Foaming Using CO2 for Bone Tissue Engineering Applications.

Authors:  Maziar Shah Mohammadi; Ehsan Rezabeigi; Jason Bertram; Benedetto Marelli; Richard Gendron; Showan N Nazhat; Martin N Bureau
Journal:  Polymers (Basel)       Date:  2020-01-17       Impact factor: 4.329

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.